Saturday 17 October 2026
Export BGXXQ’s income statement to Excel — free account
Bright Green Corporation
BGXXQ Healthcare Drug Manufacturers Specialty & Generic
0.00
0.00
NaN
Follow BGXXQ
Bright Green Corporation (BGXXQ) P/E ratio
Bright Green Corporation has no meaningful P/E ratio: its trailing twelve-month earnings is negative. Over the past ten years it has ranged from 0.0× (October 2026) to 0.0× (October 2026) — the current reading is the highest in ten years.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|
Against its own ten years
Low 0.0×
High 0.0×
Ten-year median
0.0×
Current reading's percentile
100
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| AYTU Aytu BioPharma, Inc. compare | n/m |
| TXMD TherapeuticsMD, Inc. compare | n/m |
| UPC Universe Pharmaceuticals INC compare | n/m |
| APUS Apimeds Pharmaceuticals US, Inc. compare | n/m |
| CPHI China Pharma Holdings, Inc. compare | n/m |
| BGXXQ Bright Green Corporation | n/m |
| INM InMed Pharmaceuticals Inc. compare | n/m |
| BFRI Biofrontera Inc. compare | n/m |
| SHPH Shuttle Pharmaceuticals Holdings, Inc. compare | 0.2× |
| Drug Manufacturers Specialty & Generic industry median | 19.2× |
| Healthcare sector median | 23.0× |
| Market median | 18.1× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)